$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024028789 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$936.8K	$745.3K	$2.488M
YoY Change	81.83%	22.59%	11.46%
Cost Of Revenue	$461.9K	$379.9K	$1.181M
YoY Change	88.27%	52.76%	23.74%
Gross Profit	$474.9K	$365.3K	$1.308M
YoY Change	75.97%	1.71%	2.29%
Gross Profit Margin	50.69%	49.02%	52.54%
Selling, General & Admin	$1.105M	$1.139M	$3.265M
YoY Change	40.66%	19.01%	-26.32%
% of Gross Profit	232.59%	311.84%	249.75%
Research & Development	$0.00		$0.00
YoY Change
% of Gross Profit	0.0%		0.0%
Depreciation & Amortization	$24.51K	$28.86K	$88.86K
YoY Change	17.55%	37.49%	-0.4%
% of Gross Profit	5.16%	7.9%	6.8%
Operating Expenses	$1.116M	$1.152M	$3.304M
YoY Change	40.7%	19.25%	-26.1%
Operating Profit	-$641.5K	-$786.2K	-$1.996M
YoY Change	22.52%	29.65%	-37.47%
Interest Expense		-$49.10K	-$475.4K
YoY Change		-91.27%	-129.53%
% of Operating Profit
Other Income/Expense, Net	$333.9K		-$168.6K
YoY Change	-267.37%
Pretax Income	-$307.7K	-$1.000M	$1.887M
YoY Change	-57.45%	-21.93%	-136.59%
Income Tax			$396.2K
% Of Pretax Income			21.0%
Net Earnings	-$317.2K	-$1.012M	$1.841M
YoY Change	-56.14%	-21.48%	-135.71%
Net Earnings / Revenue	-33.86%	-135.73%	74.0%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	539.1M shares	532.8M shares	490.1M shares
Diluted Shares Outstanding	535.7M shares		2.525B shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$197.9K	$736.5K	$736.5K
YoY Change	138.44%	658.53%	658.53%
Cash & Equivalents	$197.9K	$736.5K
Short-Term Investments
Other Short-Term Assets	$269.7K	$28.50K	$28.50K
YoY Change	203.52%	-59.96%	-59.96%
Inventory	$101.8K	$181.7K	$181.7K
Prepaid Expenses
Receivables	$507.4K	$426.5K	$426.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.085M	$1.373M	$1.373M
YoY Change	152.45%	166.4%	166.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$159.7K	$330.1K	$330.1K
YoY Change	81.34%	242.75%	-30.02%
Goodwill	$350.5K	$350.5K
YoY Change	0.0%	0.0%
Intangibles	$216.8K	$229.4K
YoY Change	-18.89%	-18.04%
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change		-100.0%
Total Long-Term Assets	$870.8K	$910.0K	$910.0K
YoY Change	-17.87%	-17.92%	-17.92%
TOTAL ASSETS
Total Short-Term Assets	$1.085M	$1.373M	$1.373M
Total Long-Term Assets	$870.8K	$910.0K	$910.0K
Total Assets	$1.956M	$2.283M	$2.283M
YoY Change	31.26%	40.58%	40.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$702.8K	$710.2K	$710.2K
YoY Change	-15.17%	-8.92%	-8.92%
Accrued Expenses	$522.5K	$1.252M	$1.252M
YoY Change	-39.21%	70.05%	-13.92%
Deferred Revenue	$341.8K	$500.7K
YoY Change		2111.95%
Short-Term Debt	$180.0K	$180.0K	$180.0K
YoY Change	-84.93%	-82.55%	-82.55%
Long-Term Debt Due	$232.1K	$81.91K	$81.91K
YoY Change	-85.42%	-94.8%	-94.8%
Total Short-Term Liabilities	$2.066M	$2.725M	$2.725M
YoY Change	-58.85%	-43.98%	-43.98%
LONG-TERM LIABILITIES
Long-Term Debt	$925.5K	$960.2K	$960.2K
YoY Change	47.92%	35.23%	35.23%
Other Long-Term Liabilities	$82.42K	$97.25K	$97.25K
YoY Change	-63.8%	-62.44%	-62.44%
Total Long-Term Liabilities	$1.008M	$1.057M	$1.057M
YoY Change	18.11%	9.13%	9.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.066M	$2.725M	$2.725M
Total Long-Term Liabilities	$1.008M	$1.057M	$1.057M
Total Liabilities	$3.074M	$3.924M	$3.924M
YoY Change	-47.66%	-32.73%	-34.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.18M	-$60.85M
YoY Change	-3.52%	-2.94%
Common Stock	$539.1K	$532.8K
YoY Change	20.42%	52.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.303M	-$1.641M	-$1.641M
YoY Change
Total Liabilities & Shareholders Equity	$1.956M	$2.283M	$2.283M
YoY Change	31.26%	40.58%	40.58%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$317.2K	-$1.012M	$1.841M
YoY Change	-56.14%	-21.48%	-135.71%
Depreciation, Depletion And Amortization	$24.51K	$28.86K	$88.86K
YoY Change	17.55%	37.49%	-0.4%
Cash From Operating Activities	-$651.2K	-$372.2K	-$1.602M
YoY Change	123.81%	-7.36%	1.09%
INVESTING ACTIVITIES
Capital Expenditures		$4.770K	$114.8K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$11.63K	$4.052M
YoY Change		111.45%	73566.0%
Cash From Investing Activities		$6.860K	$3.937M
YoY Change		24.73%	71479.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$275.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$112.6K	-35.27K	-1.695M
YoY Change	-59.32%	-110.35%	-246.57%
NET CHANGE
Cash From Operating Activities	-$651.2K	-372.2K	-1.602M
Cash From Investing Activities		6.860K	3.937M
Cash From Financing Activities	$112.6K	-35.27K	-1.695M
Net Change In Cash	-$538.6K	-400.6K	639.4K
YoY Change	3717.95%	622.12%	-251.22%
FREE CASH FLOW
Cash From Operating Activities	-$651.2K	-$372.2K	-$1.602M
Capital Expenditures		$4.770K	$114.8K
Free Cash Flow		-$377.0K	-$1.717M
YoY Change			8.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-53029
CY2023	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2029 Pat Booker Rd
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Antonio
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78148
CY2023	dei	City Area Code CityAreaCode	(210)
CY2023	dei	Local Phone Number LocalPhoneNumber	490-3977
CY2023	dei	Security12b Title Security12bTitle	N/A
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1273202	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	539122586	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	106
CY2023	dei	Auditor Name AuditorName	SALBERG & COMPANY, P.A.
CY2023	dei	Auditor Location AuditorLocation	Boca Raton, Florida
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	736461	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97091	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	269442	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28503	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71171	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2400	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	279	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1373118	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	515429	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	6482	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	909995	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1108609	usd
CY2023Q4	us-gaap	Assets Assets	2283113	usd
CY2022Q4	us-gaap	Assets Assets	1624038	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1576438	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	710222	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	779765	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	474515	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736393	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	717204	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590632	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	500720	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22637	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	117671	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2725072	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4864813	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	251263	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2022Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	208804	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	258895	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1057449	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	968962	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3782521	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5833775	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532818051	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532818051	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350270172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350270172	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	532818	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	350270	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55852477	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55141503	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60851714	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62693184	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4466419	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7201411	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	141884	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	150742	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2283113	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1624038	usd
CY2023	us-gaap	Revenues Revenues	2488493	usd
CY2022	us-gaap	Revenues Revenues	2232646	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1180979	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	954402	usd
CY2023	us-gaap	Gross Profit GrossProfit	1307514	usd
CY2022	us-gaap	Gross Profit GrossProfit	1278244	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1039943	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2036514	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2844783	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	601214	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	815542	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	666090	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	810413	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3303818	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4470738	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2055405	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3192494	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	481832	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-343895	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	469767	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1610062	usd
CY2023	us-gaap	Interest Expense InterestExpense	5663	usd
CY2022	us-gaap	Interest Expense InterestExpense	10027	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	175000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-168598	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1963984	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1886807	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8858	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38513	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	54195	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	60090	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1841470	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5178055	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	490113378	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	308121062	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2524605528	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	308121062	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3979041	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2174	usd
CY2022	cbnt	Common Stock Issued For Compensation CommonStockIssuedForCompensation	14250	usd
CY2022	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	217250	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	139000	usd
CY2022	cbnt	Stock Issued During Period Value In Connection With Debt StockIssuedDuringPeriodValueInConnectionWithDebt	110631	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	112500	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	55655	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	68137	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	325785	usd
CY2022	cbnt	Adjustment To Additional Paid In Capital Beneficialconversionchargeforissuanceof Series Bpreferredsharesforaccruedcompensation AdjustmentToAdditionalPaidInCapitalBeneficialconversionchargeforissuanceofSeriesBpreferredsharesforaccruedcompensation	957556	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	354215	usd
CY2022	cbnt	Adjustments To Additional Paid In Capital Beneficial Conversion Feature Buyback Related To Debt Extinguishment AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureBuybackRelatedToDebtExtinguishment	-160993	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5156478	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	83950	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53000	usd
CY2023	cbnt	Common Stock Issued For Compensation CommonStockIssuedForCompensation	26000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	214000	usd
CY2023	cbnt	Stock Issued During Period Value For Conversion Of Debt Accrued Interest And Fees StockIssuedDuringPeriodValueForConversionOfDebtAccruedInterestAndFees	200389	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	54195	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	16183	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1886807	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1886807	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88859	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	89219	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	96258	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1059752	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	90731	usd
CY2022	cbnt	Default Penalty Included In Interest Expense DefaultPenaltyIncludedInInterestExpense	206250	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	2250	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1039943	usd
CY2023	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	121950	usd
CY2022	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	298571	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21296	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7716	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	5500	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	481832	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-343895	usd
CY2023	cbnt	Gain From Sale Of Nanoshield Product Line GainFromSaleOfNanoshieldProductLine	4051709	usd
CY2023	us-gaap	Gain Loss On Sale Of Loans And Leases GainLossOnSaleOfLoansAndLeases	72	usd
CY2022	us-gaap	Gain Loss On Sale Of Loans And Leases GainLossOnSaleOfLoansAndLeases	-1080	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	175945	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	100160	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	113712	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5485	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-3376	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	746	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2121	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-82526	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-69543	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-49709	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	183647	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	299660	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-10027	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10027	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	357822	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	180609	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	478083	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	12211	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1602218	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1584918	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	114770	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5500	usd
CY2023	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	4042631	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3936861	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5500	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	250000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	291621	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	903760	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1824144	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	157149	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	160000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	237750	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1695273	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1156611	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	639370	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-422807	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519898	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	319085	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	479509	usd
CY2023	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	83950	usd
CY2022	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	217250	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1	78000	usd
CY2023	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	144000	usd
CY2022	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	278654	usd
CY2023	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	54195	usd
CY2022	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	55655	usd
CY2023	cbnt	Reclassfication Of Accrued Interest Payable To Convertible Note Payable ReclassficationOfAccruedInterestPayableToConvertibleNotePayable	81841	usd
CY2022	cbnt	Increase In Debt Discount And Paidin Capital For Shares Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForSharesIssuedWithConvertibleDebt	110631	usd
CY2022	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt	680000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	2174	usd
CY2023	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	214000	usd
CY2022	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	139000	usd
CY2023	us-gaap	Notes Issued1 NotesIssued1	198139	usd
CY2022	cbnt	Increase In Right Of Use And Lease Liability IncreaseInRightOfUseAndLeaseLiability	184375	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nature of Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and sole owner and developer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. During the years ended December 31, 2023 and 2022, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™ through May 8, 2023, the date that the nanoShield product line and related technologies were sold (see Note 16). Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder. Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Patriot Glass’s units, representing 80% of Mobile’s issued and outstanding capital stock (the “Patriot Glass Shares”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Patriot Glass Shares. The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. Initially, for two years after closing, the Company had the option to acquire the remaining 20% of Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions, LLC..</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).</p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1886807	usd
CY2023	cbnt	Gain From Sale Of Nanoshield Product Line GainFromSaleOfNanoshieldProductLine	4051709	usd
CY2023Q4	us-gaap	Cash Cash	1602218	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60851714	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2023Q4	cbnt	Working Capital WorkingCapital	1351954	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	736461	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the years ended December 31, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. </p>
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26648	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1841470	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5178055	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	490113378	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	308121062	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1841470	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5178055	usd
CY2023	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	54195	usd
CY2023	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	186536	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2082201	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5178055	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	490113378	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	308121062	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2524605528	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	308121062	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2036470250	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1618980671	shares
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk and Uncertainties</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.</p>
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	459414	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	304964	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35323	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35522	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	269442	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21296	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7716	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	119943	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	119943	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	1098091	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1501	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	181663	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	75945	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	263930	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82561	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	167624	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5500	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	5500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	123102	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	72598	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50504	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50503	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	28408	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	129414	usd
CY2021Q4	cbnt	Placement Fees PlacementFees	60000	usd
CY2023Q4	cbnt	Outstanding Principal Balance Rate OutstandingPrincipalBalanceRate	1.25	pure
CY2023Q4	cbnt	Accrued Interest Rate Per Anum AccruedInterestRatePerAnum	0.18	pure
CY2023	cbnt	Debt Instrument Trading Days DebtInstrumentTradingDays	P10D
CY2023	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.00875
CY2022Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	15000	usd
CY2023Q4	cbnt	Aggregate Payment AggregatePayment	1113091	usd
CY2023	cbnt	Gross Proceeds GrossProceeds	0.20	pure
CY2023	cbnt	Gross Proceed GrossProceed	500000	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	120000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15000	usd
CY2024Q1	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.20	pure
CY2023	cbnt	Settlement Amount SettlementAmount	1098091	usd
CY2023	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	176184	usd
CY2022	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	81045	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	176184	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2023Q4	cbnt	Aggregate Noncash Debt Discount AggregateNoncashDebtDiscount	680000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.011
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q2	cbnt	Deemed Dividents DeemedDividents	3702	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q3	cbnt	Deemed Dividents DeemedDividents	733	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	1199750	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7968	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1098091	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1282513	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	918091	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	251263	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	124781	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1918203	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	764	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	132961	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	124017	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	1785242	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1576438	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2022Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	208804	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2023Q2	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	317293	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	0	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	292241	usd
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	18900	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.004
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	160880	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2023	cbnt	Maturity Terms MaturityTerms	P12M
CY2022	cbnt	Common Stock Trading Price Per Share CommonStockTradingPricePerShare	0.009
CY2022	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.0032
CY2022	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	195000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	25400	usd
CY2022Q4	cbnt	Received Net Proceed ReceivedNetProceed	200000	usd
CY2022Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	85489	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	93631	usd
CY2023	cbnt	Preferred Stock Convertible Conversion Percentage PreferredStockConvertibleConversionPercentage	1	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	957556	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	36577	usd
CY2022Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	102000	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	31429	usd
CY2023Q4	cbnt	Preferred Stock Stated Value PreferredStockStatedValue	1515000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	275000	shares
CY2023Q1	cbnt	Stock Issued During Period Value For Accrued Compensation StockIssuedDuringPeriodValueForAccruedCompensation	53000	usd
CY2023Q1	cbnt	Stock Issued During Period Shares For Accrued Compensation StockIssuedDuringPeriodSharesForAccruedCompensation	9636364	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4000000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48000	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.012
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	21000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3000000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	54000	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.018
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2500000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	31250	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0125
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	5454545	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.011
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	55000	usd
CY2022Q4	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	3000000	shares
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24000	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.008
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6666667	shares
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.006
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	40000	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5000000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22500	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	22500	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16950	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0011
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	16950	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1000000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4500	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2250	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2250	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	500000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14250	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0285
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	14250	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.011
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.012
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26000	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0104
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42183	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	82387	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14270120	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.14
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3500000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.014
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	800000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.037
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	16970120	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.119
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2000000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.021
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2023	us-gaap	Common Stock Conversion Basis CommonStockConversionBasis	In connection with the September 2022 GS Capital Note, on September 6, 2022, the Company issued 3,300,000 shares of its common stock as a commitment fee and the Company issued 773,626 shares of its common stock to the placement agent as fee for the capital raises. The aggregate of 4,073,626 shares of common stock issued were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the September 2022 Note (See Note 8).
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	112500	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0075
CY2022Q4	cbnt	Stated Redemption Value StatedRedemptionValue	25000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.011
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q2	cbnt	Deemed Dividents DeemedDividents	3702	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q3	cbnt	Deemed Dividents DeemedDividents	733	usd
CY2023	cbnt	Voting Percentage VotingPercentage	0.10	pure
CY2023	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
CY2023	cbnt	Incentive Stock Options IncentiveStockOptions	50000000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	11445698	shares
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	29451070	shares
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	175000	usd
CY2017Q4	cbnt	Annual Base Salary AnnualBaseSalary	300000	usd
CY2017Q4	cbnt	Annual Base Salary Rate AnnualBaseSalaryRate	0.10	pure
CY2017Q4	us-gaap	Public Utilities Amount Of Allowance For Funds Used During Construction Equity Costs Capitalized Only For Rate Making Purposes PublicUtilitiesAmountOfAllowanceForFundsUsedDuringConstructionEquityCostsCapitalizedOnlyForRateMakingPurposes	1000000	usd
CY2017Q4	cbnt	Capital Raise Rate CapitalRaiseRate	0.05	pure
CY2017Q4	cbnt	Common Stock Shares Acquired CommonStockSharesAcquired	3000000	shares
CY2017Q4	cbnt	Common Stock Shares Acquired Per Share CommonStockSharesAcquiredPerShare	0.31
CY2017Q4	cbnt	Stock Options Shares Issued StockOptionsSharesIssued	500000	shares
CY2017Q4	cbnt	Strike Price StrikePrice	0.85
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
CY2023	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2022Q4	cbnt	Bonus Percentage BonusPercentage	0.10	pure
CY2022Q4	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	144000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	144	shares
CY2021Q1	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	2	usd
CY2023	cbnt	Bonus Percentage BonusPercentage	0.10	pure
CY2023	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	162000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	312000	usd
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	312	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
CY2023	cbnt	Issued Percentage IssuedPercentage	0.20	pure
CY2023	cbnt	Outstanding Percentage OutstandingPercentage	0.20	pure
CY2023	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
CY2023	cbnt	Option Period Percentage OptionPeriodPercentage	0.20	pure
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	240000	usd
CY2023Q3	cbnt	Share Value Percentage ShareValuePercentage	3	pure
CY2023	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	25000	usd
CY2023Q4	cbnt	Transaction Percentage TransactionPercentage	0.065	pure
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	322007	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2022Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	480293	usd
CY2023	us-gaap	Revenues Revenues	2488493	usd
CY2022	us-gaap	Revenues Revenues	2232646	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88859	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	89219	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	475430	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1620089	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1886807	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5156478	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023	us-gaap	Revenues Revenues	2488493	usd
CY2022	us-gaap	Revenues Revenues	2232646	usd
CY2020	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	5283	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	cbnt	Lease Agreemen Description LeaseAgreemenDescription	the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025.
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	cbnt	Lease Agreemen Description LeaseAgreemenDescription	the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025.
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
CY2023	cbnt	Rent Expenses RentExpenses	101501	usd
CY2022	cbnt	Rent Expenses RentExpenses	167875	usd
CY2023Q4	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	120678	usd
CY2022Q4	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	104881	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157752	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	376566	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	117671	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	258895	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	75866	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	67988	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	39200	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	183054	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25302	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157752	usd
CY2022Q2	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.06	pure
CY2022Q2	us-gaap	Debt Conversion Original Debt Due Date Of Debt Day Month And Year DebtConversionOriginalDebtDueDateOfDebtDayMonthAndYear	2024-05-02
CY2023	us-gaap	Interest Expense InterestExpense	5663	usd
CY2023Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
CY2023Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	50000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15690	usd
CY2023	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4000000	usd
CY2023	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	1989755	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	396229	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1081240	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-64617	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	506677	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-331612	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	574563	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2176983	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2512665	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4070	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2181053	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2512665	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2181053	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2512665	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	10386000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	331612	usd
CY2024Q1	cbnt	Fund Amount FundAmount	125000	usd
CY2024Q1	cbnt	Original Issue Discounts OriginalIssueDiscounts	13000	usd
CY2024Q1	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	19000	usd
CY2023Q1	cbnt	Interest Charge Rate Percentage InterestChargeRatePercentage	0.12	pure
CY2023	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	175840000000	usd
CY2023	us-gaap	Guarantee Obligations Liquidation Proceeds Percentage GuaranteeObligationsLiquidationProceedsPercentage	2.20	pure
CY2023	cbnt	Conversion Price Percentage ConversionPricePercentage	-0.65	pure
CY2023	cbnt	Discount Rates DiscountRates	0.35	pure
CY2023Q4	us-gaap	Security Deposit SecurityDeposit		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2023	cbnt	Default Penalty Included In Interest Expense DefaultPenaltyIncludedInInterestExpense		usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2022	cbnt	Gain From Sale Of Nanoshield Product Line GainFromSaleOfNanoshieldProductLine		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1		usd
CY2022	cbnt	Reclassfication Of Accrued Interest Payable To Convertible Note Payable ReclassficationOfAccruedInterestPayableToConvertibleNotePayable		usd
CY2023	cbnt	Increase In Debt Discount And Paidin Capital For Shares Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForSharesIssuedWithConvertibleDebt		usd
CY2023	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023	cbnt	Increase In Right Of Use And Lease Liability IncreaseInRightOfUseAndLeaseLiability		usd
CY2022	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax		usd
CY2022	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2023Q4	cbnt	Goodwill Useful Lifes GoodwillUsefulLifes
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
0001213900-24-028789-index-headers.html	Edgar Link	pending
0001213900-24-028789-index.html	Edgar Link	pending
0001213900-24-028789.txt	Edgar Link	pending
0001213900-24-028789-xbrl.zip	Edgar Link	pending
cbnt-20231231.xsd	Edgar Link	pending
ea0202661-10k_cbond.htm	Edgar Link	pending
ea020266101ex21-1_cbond.htm	Edgar Link	pending
ea020266101ex23-1_cbond.htm	Edgar Link	pending
ea020266101ex31-1_cbond.htm	Edgar Link	pending
ea020266101ex31-2_cbond.htm	Edgar Link	pending
ea020266101ex32-1_cbond.htm	Edgar Link	pending
ea020266101ex32-2_cbond.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
cbnt-20231231_def.xml	Edgar Link	unprocessable
cbnt-20231231_lab.xml	Edgar Link	unprocessable
cbnt-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0202661-10k_cbond_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cbnt-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2024 Q1 Form 10-K Financial Statement

#000121390024028789 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2024 Q1 Form 10-K Financial Statement

#000121390024028789 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt